Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Poupon

. Primary biliary cirrhosis: A 2010 update. J Hepatol 2010;52:745-58.

Doycheva

. Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease. World J Hepatol 2011;3:93-8.

Sorokin

Brown

Thompson

. Primary biliary cirrhosis, hyperlipidaemia, and atherosclerotic risk: A systematic review. Atherosclerosis 2007;194:293-9.

Hickman

Dywer

Masarei

JRL

. Pseudohyponatraemia, hypercholesterolaemia, and primary biliary cirrhosis. J Clin Pathol 1989;42: 167-71.

Chang

. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J Lipid Res 2004;45:2116-22.

Franceschini

Busnach

Chiesa

Sirtori

. Management of lipoprotein-X accumulation in severe cholestasis by semi-elective LDL apheresis. Am J Med 1991;90:633-8.

Lindor

Gershwin

Poupon

. American Association for the Study of Liver Diseases Practice Guidelines: primary biliary cirrhosis. Hepatology 2009;50:291-308.

Rosenson

Baker

Chow

Hay

. Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. Gastroenterology 1990;98(5 Pt 1):1351-7.

Alallam

Barth

Heathcote

. Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports. Can J Gastroenterol 2008;22:505-7.

10.

Cohen

Ambinder

Wolke

. Role of plasmapheresis in primary biliary cirrhosis. Gut 1985;26:291-4.

11.

Radchenko

. Plasmapheresis efficacy in the treatment of patients with chronic cholestatic hepatitis and primary biliary cirrhosis [in Russian]. Lik Sprava 1995;5-6:160-3.

The use of plasmapheresis in managing primary biliary cirrhosis presenting with profound hypercholesterolaemia

Abstract

Get full access to this article

References